NextCure, Inc.
NXTC
$8.21
-$0.07-0.85%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 29.84% | -10.38% | -0.34% | 0.87% | 0.57% |
| Total Depreciation and Amortization | -45.40% | -33.53% | -23.73% | -17.28% | -18.40% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 57.37% | -58.05% | -58.51% | -50.15% | -45.54% |
| Change in Net Operating Assets | -573.24% | 192.27% | -78.95% | -15.10% | -111.18% |
| Cash from Operations | 31.68% | -21.34% | -21.59% | -9.97% | -18.11% |
| Capital Expenditure | -- | -- | -- | 106.53% | 78.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -28.87% | -56.04% | -54.18% | -50.07% | -19.63% |
| Cash from Investing | -28.60% | -55.61% | -53.79% | -49.51% | -18.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,008.27% | 17,230.77% | 16,243.75% | 1,055.06% | 1,055.06% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 948.78% | 16,375.52% | 15,394.44% | 1,055.06% | 1,055.06% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 164.98% | -291.99% | -111.92% | -349.05% | -1,262.60% |